|
Serum 25(OH)D concentrations in the control group by polymorphisms in the vitamin D receptor gene |
||||
| Polymorphism |
Genotype |
Pa |
||
|
|
||||
| TaqI |
TT: 49.8 (32.6–67.5) |
Tt: 47.1 (32.5–66.1) |
tt: 48.1 (32.7–69.8) |
0.52 |
| FokI |
FF: 49.2 (33.0–66.9) |
Ff: 48.2 (32.4–67.4) |
ff: 47.9 (31.7–69.7) |
0.85 |
| VDR-5132 |
CC: 49.1 (32.9–66.9) |
CT: 48.6 (32.6–68.3) |
TT: 47.7 (31.6–66.9) |
0.78 |
| Cdx2 |
GG: 48.5 (32.5–67.4) |
GA: 48.7 (31.9–66.2) |
AA: 50.7 (35.0–68.6) |
0.56 |
|
Values are expressed as median serum 25-hydroxyvitamin D (25 [OH]D; 25th to 75th percentile) in nmol/l. aWilcoxon rank-sum test for median differences by genotype. | ||||
Abbas et al. Breast Cancer Research 2008 10:R31 doi:10.1186/bcr1994 |
||||